NF-κB、c-erbB-2和VEGF-C在乳腺癌组织中的表达与临床转移、分期间的关系
被引量:3
摘要
1材料与方法 1.1材料 所有标本取自徐州医学院附属医院2003-2005年间手术切除标本。97例乳腺癌患者均为女性,年龄22~75岁,平均50岁,有腋窝淋巴结转移者54例。诊断、病理学分期按照中国抗癌协会《常见恶性肿瘤诊治规范.乳腺癌分册》的诊断标准进行,其中Ⅰ期21例,Ⅱ期53例,Ⅲ期23例。所有患者术前均未行化疗、放疗、内分泌治疗。
出处
《诊断病理学杂志》
CSCD
2009年第1期58-59,共2页
Chinese Journal of Diagnostic Pathology
参考文献12
-
1Biswas DK, Shi Q, Baily S, et al. NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis [J]. Proc Natl Acad Sci U S A, 2004, 101(27):10137- 10142.
-
2Wang CY, Guttridge DC, Mayo MW, et al. NF-kappaB induces expression of the Bcl-2 homologue Al/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis [ J ]. Mol Cell Biol, 1999, 19 (9) : 5923 - 5929.
-
3Sosic D, Richardson JA, Yu K, et al. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity[J]. Cell, 2003, 112(2) : 169 - 180.
-
4Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network [J]. Nat Rev Mol Cell Biol, 2001, 2(2) : 127 - 137.
-
5Meric F, Hung MC, Hortobagyi GN, et al. HER2/neu in the management of invasive breast cancer[J]. J Am Coll Surg, 2002, 194 (4) : 488 - 501.
-
6Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis[J]. Nat Med, 2001, 7(2):192- 198.
-
7Pytowski B, Goldman J, Persaud K, et al. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody[J]. J Nail Cancer Inst, 2005, 97(1):14- 21.
-
8He Y, Kozaki K, Karpanen T, et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vasctdar endothelial growth factor receptor 3 signaling[J]. J Natl Cancer Inst, 2002,94(11) :819 - 825.
-
9Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Fh4 (VEGFR- 3) and KDR (VEGFR-2) receptor tyrosine kinases[J]. EMBO J, 1996, 15(2) : 290 - 298.
-
10Pianetti S, Arsura M, Romieu-Mourez R, et al. Her-2/neu overexpression induces NF-kappaB via a P13-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-atpha that can be inhibited by the tumorsuppressor PTEN [ J ]. Oncogene, 2001, 20 (11) : 1287 - 1299.
同被引文献20
-
1胡帅尔,张雅洁,崔玉梅,张惠球.VEGF-A和VEGF-C在乳腺癌组织中的表达及其意义[J].癌症,2005,24(9):1076-1079. 被引量:15
-
2徐卫国,王刚,邹玉环,杨小青,宋纪宁,杨文琦,李明,王文雅,赵光明.血管内皮生长因子在乳腺浸润性导管癌中的表达及意义[J].中国综合临床,2007,23(4):338-340. 被引量:5
-
3罗秉庆,郑绍光,唐青梅,龚广,陈琼.COX-2、E-cadherin和KAI1在乳腺浸润性导管癌中的表达及意义[J].诊断病理学杂志,2007,14(3):215-217. 被引量:9
-
4Tapia C, Savic S, Wagner U, et al. HER- 2 gene status in primary breast cancers and matched distant metastases[J ]. Breast Cancer Res, 2007,9(3) : 31.
-
5Toi M, Matsumoto T, Bando H. Vascular endothelial growth factor : its prognostic, predictive, and therapeutic implications[J ]. Lancet Oncol, 2001,2(11) : 667.
-
6Tsutsui S, Kume M, Era S, et al. Prognostic value of microvessel density in invasive ductal carcinoma of the breast [J ]. Breast Cancer, 2003,10(4) : 312.
-
7Konecny GE, Meng YG, Untch M, et al. Association between HER - 2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients[J] . Clin Cancer Res, 2004, 10 (5):1 706.
-
8Perrone G,Vincenzi B,Santini D,et al.Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF):microvessel density (MVD) and clinico-pathological features in colon cancer[J].Cancer Lett,2004,208(2):227.
-
9Koyama Y,Kaneko K,Akazawa K,et al.Vascular endothelial growth factor-C and vascular endothelial growth factor-d messenger RNA expression in breast cancer:association with lymph node metastasis[J].Clin Breast Cancer,2003,4(5):354.
-
10Bendardaf R,Elzagheid A,Lamlum H,et al.E-cadherin,CD44a and CD44v6 correlate with tumour differentiation in colorectal cancer.Oncol Rep,2005,13:831-835.
引证文献3
-
1朱霞,杨黎,冉立.乳腺癌C-erbB-2与肿瘤血管生成的关系及其临床意义[J].中国药房,2009,20(23):1790-1792.
-
2罗民,盛辉,苑春莉,周娜,王医术.血管内皮生长因子和微血管密度与乳腺浸润性导管癌生物学行为的关系[J].中国实验诊断学,2010,14(7):1066-1067. 被引量:6
-
3王洪远,费洪钧,梁雅静.食管癌组织中上皮钙黏素、CD44v6和血管内皮生长因子C表达与淋巴结转移的关系[J].肿瘤研究与临床,2010,22(11):755-757. 被引量:2
二级引证文献8
-
1张渊,江泉,陈剑,张云霄,何竹,王登山,顾晓鸣.乳腺肿瘤超声造影与微血管密度及血管内皮生长因子的相关性研究[J].中华超声影像学杂志,2012,21(1):52-55. 被引量:19
-
2庆琳琳,胡继春,赵晓志.食管癌组织中ERK与VEGF-C、CD44v6表达的相关性研究[J].河北医药,2013,35(3):360-361. 被引量:5
-
3王斌,王晓文,伊丽娜,朱丽萍.乳腺浸润性导管癌病灶转移的相关因素分析[J].中国现代普通外科进展,2013,16(9):720-721. 被引量:1
-
4庆琳琳,胡继春.结直肠腺癌组织中c-JUN氨基末端激酶、E-选择素、血管内皮生长因子-D蛋白表达的临床意义[J].中国医药导报,2015,12(5):95-98. 被引量:3
-
5崔艳婷,谢小红,顾锡冬,胡袁媛,周长玉.乳腺癌患者MVD VEGF与Ki-67淋巴结转移的相关性分析[J].浙江临床医学,2018,20(1):12-14. 被引量:8
-
6孟庆鑫,王可心,李丹,赵梓君.乳腺癌彩色多普勒血流显像与微血管密度及乳腺癌预后的相关性研究[J].血管与腔内血管外科杂志,2018,4(5):439-443. 被引量:5
-
7赵毅玲,王静,唐杰露,李彩娟,单叔煤,孙迎燕.乳腺癌血流动力学的超声表现与血管内皮生长因子及微血管密度的诊断标准[J].血管与腔内血管外科杂志,2018,4(5):444-448. 被引量:9
-
8李琼,薛晓红,江科,陆清,裴建遇,黎伟.乳腺癌患者血清与肿瘤组织中VEGF、ES表达和微血管密度的关系[J].世界中西医结合杂志,2016,11(12):1676-1678. 被引量:7
-
1崔友红,卢玉波,杨宏英.宫颈癌微转移的研究现状[J].现代肿瘤医学,2008,16(11):1998-2001. 被引量:4
-
2许超,王强,蔡清萍,颜荣林,李晓凯,陈学云.CXCR3在结直肠癌组织中的表达及临床意义[J].中华实验外科杂志,2008,25(5):609-611. 被引量:4
-
3黄思玲,周家德.妇科肿瘤微转移研究进展[J].安徽医药,2010,14(1):110-112. 被引量:2
-
4吴春秀,魏向群.宫颈癌微转移的研究进展[J].现代肿瘤医学,2014,22(7):1718-1720. 被引量:3
-
5苏丽萍,张进平,陈晋,王缨,熊思东.CXCR4在肺癌组织中的表达及临床意义[J].中国癌症杂志,2005,15(2):97-100. 被引量:23
-
6黄蓓,武忠弼,阮幼冰.人肝癌组织nm23的表达及其与转移的关系[J].临床与实验病理学杂志,1997,13(1):25-26. 被引量:8
-
7董娜娜,段晓峰,张倜,李慧锴,周洪渊,李强.103例肝内胆管癌临床病理及诊治分析[J].中国肿瘤临床,2012,29(6):340-342. 被引量:13
-
8张传灼,李文美,杨小勇.胰腺实性假乳头状瘤的诊断与治疗[J].中国医药科学,2012,2(1):61-62.
-
9陈亚平,姜晓晓,冯守信,韩正祥,杜秀平,蒋冠.老年非小细胞肺癌立体定向体部放疗联合化疗的临床观察[J].中华肿瘤防治杂志,2015,22(22):1779-1782. 被引量:14
-
10姚丹,任泽强,张蓬波,张秀忠,龚帅,刘利,王吉科.肝左叶黏液性囊腺癌1例报道[J].中国普外基础与临床杂志,2016,23(4):449-449.